These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1700927)
1. The concept of locally advanced gastric cancer. Effect of treatment on outcome. The Gastrointestinal Tumor Study Group. Cancer; 1990 Dec; 66(11):2324-30. PubMed ID: 1700927 [TBL] [Abstract][Full Text] [Related]
2. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group. Cancer; 1982 May; 49(9):1771-7. PubMed ID: 6176313 [TBL] [Abstract][Full Text] [Related]
3. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer. Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795 [TBL] [Abstract][Full Text] [Related]
4. New developments in the treatment of gastric carcinoma. Wilke H; Preusser P; Fink U; Achterrath W; Meyer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Geerlings H Semin Oncol; 1990 Feb; 17(1 Suppl 2):61-70. PubMed ID: 2305269 [TBL] [Abstract][Full Text] [Related]
5. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma. Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma. Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant 5-FU and MeCCNU improves survival following curative gastrectomy for adenocarcinoma. Clark JL; Barcewicz P; Nava HR; Goodwin PS; Douglass HO Am Surg; 1990 Jul; 56(7):423-7. PubMed ID: 2368986 [TBL] [Abstract][Full Text] [Related]
8. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757 [TBL] [Abstract][Full Text] [Related]
9. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536 [TBL] [Abstract][Full Text] [Related]
10. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051 [TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Krook JE; O'Connell MJ; Wieand HS; Beart RW; Leigh JE; Kugler JW; Foley JF; Pfeifle DM; Twito DI Cancer; 1991 May; 67(10):2454-8. PubMed ID: 2015545 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554 [TBL] [Abstract][Full Text] [Related]
13. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
14. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial. Hazel JJ; Thirlwell MP; Huggins M; Maksymiuk A; MacFarlane JK J Can Assoc Radiol; 1981 Sep; 32(3):164-5. PubMed ID: 7028759 [TBL] [Abstract][Full Text] [Related]
15. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer. Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699 [TBL] [Abstract][Full Text] [Related]
17. [ACNU and methyl-CCNU in combination chemotherapy for advanced gastric cancer: a randomized comparative study. Shanghai ACNU Collaborative Study Group]. Xiao S; Li D; Zhang D Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):30-3. PubMed ID: 8732108 [TBL] [Abstract][Full Text] [Related]
18. [Palliative surgery combined with oxaliplatin-based chemotherapy in treatment of patients with advanced gastric cancer]. Chen YB; Guan YX; Zhan YQ; Li W; Sun XW; Li YF; Xu DZ Ai Zheng; 2004 Nov; 23(11 Suppl):1520-2. PubMed ID: 15566671 [TBL] [Abstract][Full Text] [Related]
20. Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies. Levi JA; Fox RM; Tattersall MH; Woods RL; Thomson D; Gill G J Clin Oncol; 1986 Sep; 4(9):1348-55. PubMed ID: 3528404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]